Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI) as a Pre-Clinical or Pro-Dromal Alzheimers Diagnosis (Prognosis) for Optimum Outcomes

NCT02843529 is registered in ClinicalTrials.gov with Altoida as lead sponsor.

NCT NCT02843529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02843529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI) as a Pre-Clinical or Pro-Dromal Alzheimers Diagnosis (Prognosis) for Optimum Outcomes
Lead sponsor
Altoida
Phase
Not applicable
Overall status
Completed
Start date
October 17, 2016
Completion date
February 21, 2020
Enrollment
548 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive impairment, dementia, memory disorders, mild cognitive impairment, presymptomatic disease